Aetna to Be Acquired by CVS for $69 Billion
12.04.17
This is only gets display when printing
Simpson Thacher is advising Aetna’s Board of Directors in connection with CVS Health’s (NYSE: CVS) proposed acquisition of Aetna (NYSE: AET) for $69 billion. The transaction is expected to close in the second half of 2018, subject to approval by CVS Health and Aetna shareholders, regulatory approvals and other customary closing conditions.
Aetna is one of the nation's leading diversified health care benefits companies, serving approximately 36.7 million people and offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services. CVS Health is a pharmacy innovation company enabling people, businesses and communities to manage health in more affordable and effective ways.
Alan Klein, Co-Head of Simpson Thacher's Global Mergers and Acquisition Practice, is representing the Aetna Board of Directors.